Unnatural Products Announces BridgeBio Exercises Option To License Macrocyclic Peptide Candidates Discovered Using UNP's AI-Enabled Massively Parallel Chemistry Platform

BenzingaDec 3 08:05 ET

Mizuho Securities Maintains BridgeBio Pharma(BBIO.US) With Buy Rating

Moomoo NewsNov 27 01:31 ET · Ratings

BridgeBio Pharma Receives Buy Rating Following Attruby's FDA Approval and Strategic Milestones

TipRanksNov 27 00:35 ET · Ratings

Trending Stocks Today | Ambarella Shoots up 24.58% Post-Market

Moomoo NewsNov 26 16:20 ET

BridgeBio Selects PANTHERx Rare Specialty Pharmacy for Distribution of Attruby (Acoramidis)

PR NewswireNov 26 11:31 ET

BridgeBio Stock Up on FDA Approval of Cardiovascular Drug

Zacks Nov 26 10:05 ET